David W Cushman

Title: David W Cushman: Innovator in Pharmaceutical Research

Introduction

David W Cushman is a notable inventor based in Lawrenceville, NJ, recognized for his contributions to the pharmaceutical field. With one patent to his name, he is making strides in the treatment of cGMP-associated conditions, which significantly impact human health.

Latest Patents

Cushman's patent, titled "Quinazolinone inhibitors of cGMP phosphodiesterase," features novel quinazolinone compounds. These compounds are aimed at treating conditions such as erectile dysfunction. The patent also includes methods of using these compounds and pharmaceutical compositions that incorporate them, reflecting Cushman's innovative approach to healthcare solutions.

Career Highlights

David W Cushman is currently affiliated with the renowned Bristol-Myers Squibb Company, a leader in biotechnology and pharmaceutical innovation. His work at this distinguished organization exemplifies his commitment to advancing medicinal chemistry and improving patient outcomes through innovative treatments.

Collaborations

Cushman collaborates with other leading professionals in the field, including John E Macor and David P Rotella. Their teamwork and shared expertise contribute significantly to the advancement of pharmaceutical science, showcasing the power of collaboration in achieving innovative breakthroughs.

Conclusion

David W Cushman's work exemplifies the spirit of innovation that drives progress in the pharmaceutical industry. With his patented research, he is poised to make meaningful contributions to the treatment of cGMP-associated conditions, highlighting the importance of inventors in the ongoing quest for medical advancements.